<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36228563</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-460X</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of diabetes and its complications</Title><ISOAbbreviation>J Diabetes Complications</ISOAbbreviation></Journal><ArticleTitle>Post-COVID syndrome, inflammation, and diabetes.</ArticleTitle><Pagination><StartPage>108336</StartPage><MedlinePgn>108336</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jdiacomp.2022.108336</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1056-8727(22)00248-3</ELocationID><Abstract><AbstractText>The raging COVID-19 pandemic is in its third year of global impact. The SARS CoV 2 virus has a high rate of spread, protean manifestations, and a high morbidity and mortality in individuals with predisposing risk factors. The pathophysiologic mechanisms involve a heightened systemic inflammatory state, cardiometabolic derangements, and varying degrees of glucose intolerance. The latter can be evident as significant hyperglycemia leading to new-onset diabetes or worsening of preexisting disease. Unfortunately, the clinical course beyond the acute phase of the illness may persist in the form of a variety of symptoms that together form the so-called "Long COVID" or "Post-COVID Syndrome". It is thought that a chronic, low-grade inflammatory and immunologic state persists during this phase, which may last for weeks or months. Although numerous insights have been gained into COVID-related hyperglycemia and diabetes, its prediction, course, and management remain to be fully elucidated.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rizvi</LastName><ForeName>Ali A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Central Florida College of Medicine, Orlando, FL, USA. Electronic address: Ali.Rizvi@ucf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kathuria</LastName><ForeName>Amita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Mahmeed</LastName><ForeName>Wael</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Heart and Vascular Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Rasadi</LastName><ForeName>Khalid</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Medical Research Center, Sultan Qaboos University, Muscat, Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Alawi</LastName><ForeName>Kamila</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Training and Studies, Royal Hospital, Ministry of Health, Muscat, Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banach</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Poland; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Yajnavalka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Mohamed Bin Rashid University, Dubai, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceriello</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS MultiMedica, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cesur</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinic of Endocrinology, Ankara G&#xfc;ven Hospital, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cosentino</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit of Cardiology, Karolinska Institute and Karolinska University Hospital, University of Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galia</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedicine, Neurosciences and Advanced Diagnostics (Bind), University of Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goh</LastName><ForeName>Su-Yen</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Singapore General Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janez</LastName><ForeName>Andrej</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalra</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Bharti Hospital &amp; BRIDE, Karnal, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kempler</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine and Oncology, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lessan</LastName><ForeName>Nader</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The Research Institute, Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lotufo</LastName><ForeName>Paulo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center for Clinical and Epidemiological Research, University Hospital, University of S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papanas</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Diabetes Center, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Raul D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Heart Institute (InCor) University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil; Hospital Israelita Albert Einstein, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stoian</LastName><ForeName>Anca P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Diabetes, Nutrition and Metabolic Diseases, Carol Davila University, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toth</LastName><ForeName>Peter P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viswanathan</LastName><ForeName>Vijay</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Diabetes Research Centre, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzo</LastName><ForeName>Manfredi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Complications</MedlineTA><NlmUniqueID>9204583</NlmUniqueID><ISSNLinking>1056-8727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006943" MajorTopicYN="Y">Hyperglycemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">New-onset diabetes</Keyword><Keyword MajorTopicYN="N">Newly diagnosed diabetes</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">SARS CoV-2</Keyword><Keyword MajorTopicYN="N">Syndemia</Keyword><Keyword MajorTopicYN="N">Type 2 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>13</Day><Hour>18</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36228563</ArticleId><ArticleId IdType="pmc">PMC9534783</ArticleId><ArticleId IdType="doi">10.1016/j.jdiacomp.2022.108336</ArticleId><ArticleId IdType="pii">S1056-8727(22)00248-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Menachery V.D., Yount B.L., Jr., Debbink K., Jr., et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat Med. 2015;21:1508&#x2013;1513. Erratum in: Nat Med. 2016;22(4):446. Erratum in: Nat Med. 2020;26(7):1146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4797993</ArticleId><ArticleId IdType="pubmed">26552008</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID Symptom Study  How long does COVID-19 last? https://covid.joinzoe.com/post/covid-long-term Available from.</Citation></Reference><Reference><Citation>O'Kelly B., Vidal L., Avramovic G., et al. Assessing the impact of COVID-19 at 1 year using the SF-12 questionnaire: data from the anticipate longitudinal cohort study. Int J Infect Dis. 2022;S1201&#x2013;9712:00152&#x2013;00157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8920113</ArticleId><ArticleId IdType="pubmed">35301101</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., et al. COVERSCAN Study Investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., et al. TLC Study Group. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114:428&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Batawi S., Tarazan N., Al-Raddadi R., et al. Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS) Health Qual Life Outcomes. 2019;17:101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6560892</ArticleId><ArticleId IdType="pubmed">31186042</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11:269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372 Epub. 01/24.</Citation><ArticleIdList><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long COVID-mechanisms, risk factors, and management. BMJ. 2021;374</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Bektas A., Schurman S.H., Franceschi C., Ferrucci L. A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging? Immun Ageing. 2020;17:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7443812</ArticleId><ArticleId IdType="pubmed">32849908</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.M., Shang Y.M., Song W.B., et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiss R., Grodzki D.M., Horger W., Uder M., Nagel A.M., Bickelhaupt S. High-performance low field MRI enables visualization of persistent pulmonary damage after COVID-19. Magn Reson Imaging. 2021;76:49&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7673210</ArticleId><ArticleId IdType="pubmed">33220447</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., et al. COVID19-ALC research group. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82:378&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A.S., Wong A.W., Hague C.J., et al. A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2021;76:402&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">33273023</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. Erratum in: JAMA Cardiol. 2020;5(11):1308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021:1&#x2013;18. (Lond)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C., Lin J.C., Sheriff S., Maudsley A.A., Younger J.W. Evidence of widespread metabolite abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging Behav. 2020;14:562&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612467</ArticleId><ArticleId IdType="pubmed">30617782</ArticleId></ArticleIdList></Reference><Reference><Citation>Metwally A.A., Mehta P., Johnson B.S., Nagarjuna A., Snyder M.P. COVID-19-induced new-onset diabetes: trends and technologies. Diabetes. 2021 Dec;70:2733&#x2013;2744.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8660988</ArticleId><ArticleId IdType="pubmed">34686519</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalakis K., Ilias I. COVID-19 and hyperglycemia/diabetes. World J Diabetes. 2021;12:642&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8107977</ArticleId><ArticleId IdType="pubmed">33995851</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasbinder A., et al. On behalf of the ISIC Study Group. Inflammation, hyperglycemia, and adverse outcomes in individuals with diabetes mellitus hospitalized for COVID-19. Diabetes Care. 2022;45:692&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8918261</ArticleId><ArticleId IdType="pubmed">35045184</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianchandani R., Esfandiari N.H., Ang L., et al. Managing hyperglycemia in the COVID-19 inflammatory storm. Diabetes. 2020;69:2048&#x2013;2053.</Citation><ArticleIdList><ArticleId IdType="pubmed">32778570</ArticleId></ArticleIdList></Reference><Reference><Citation>Scialo F., Daniele A., Amato F., et al. The major cell entry receptor for SARS-CoV-2. Lung. 2020;198:867&#x2013;877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7653219</ArticleId><ArticleId IdType="pubmed">33170317</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S., Casaro E.B., Rangel &#xc9;.B. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40:905&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y., He L., Zhang Q., et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203:622&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167761</ArticleId><ArticleId IdType="pubmed">15141376</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Huneidi W., Hamad M., Taneera J. Expression of SARS-CoV-2 receptor "ACE2" in human pancreatic &#x3b2; cells: to be or not to be! Islets. 2021;13:106&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8528404</ArticleId><ArticleId IdType="pubmed">34304698</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuraishy H.M., Al-Gareeb A.I., Alblihed M., Guerreiro S.G., Cruz-Martins N., Batiha G.E. COVID-19 in relation to hyperglycemia and diabetes mellitus. Front Cardiovasc Med. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189260</ArticleId><ArticleId IdType="pubmed">34124187</ArticleId></ArticleIdList></Reference><Reference><Citation>Unnikrishnan R., Misra A. Diabetes and COVID19: a bidirectional relationship. Nutr Diabetes. 2021;11:21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8223528</ArticleId><ArticleId IdType="pubmed">34168110</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao S., Yang Q., Pan R., Yu X., Chen Y. Interaction of severe acute respiratory syndrome coronavirus 2 and diabetes. Front Endocrinol. 2021;12 (Lausanne)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8527093</ArticleId><ArticleId IdType="pubmed">34690930</ArticleId></ArticleIdList></Reference><Reference><Citation>Boddu S.K., Aurangabadkar G., Kuchay M.S. New onset diabetes, type 1 diabetes and COVID-19. Diabetes Metab Syndr. 2020;14:2211&#x2013;2217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7669477</ArticleId><ArticleId IdType="pubmed">33395782</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner G., Fraker C.A. Natural killer cells as key mediators in type I diabetes immunopathology. Front Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8417893</ArticleId><ArticleId IdType="pubmed">34489972</ArticleId></ArticleIdList></Reference><Reference><Citation>Valencia I., Peir&#xf3; C., Lorenzo &#xd3;., S&#xe1;nchez-Ferrer C.F., Eckel J., Romacho T. DPP4 and ACE2 in diabetes and COVID-19: therapeutic targets for cardiovascular complications? Front Pharmacol. 2020;11:1161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7426477</ArticleId><ArticleId IdType="pubmed">32848769</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S., Bae J.H., Kwon H.S., Nauck M.A. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17:11&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7664589</ArticleId><ArticleId IdType="pubmed">33188364</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association  Inpatient insulin protocols - COVID-19. https://professional.diabetes.org/content-page/inpatient-insulin-protocols-covid-19</Citation></Reference><Reference><Citation>Cromer S.J., Colling C., Schatoff D., et al. Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: associated factors, short-term outcomes, and long-term glycemic phenotypes. J Diabetes Complications. 2022;36</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8813764</ArticleId><ArticleId IdType="pubmed">35148936</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Riddle M.C., Bakris G., Blonde L., et al. A lesson from 2020: public health matters for both COVID-19 and diabetes. Diabetes Care. 2021;44:8&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">33571952</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregg E.W., Sophiea M.K., Weldegiorgis M. Diabetes and COVID-19: population impact 18 months into the pandemic. Diabetes Care. 2021;44:1916&#x2013;1923.</Citation><ArticleIdList><ArticleId IdType="pubmed">34244333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko J.Y., Danielson M.L., Town M., et al. COVID-NET Surveillance Team. Risk factors for coronavirus disease 2019 (COVID-19)-associated hospitalization: COVID-19-associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System. Clin Infect Dis. 2021;72:e695&#x2013;e703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543371</ArticleId><ArticleId IdType="pubmed">32945846</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L., Shao M., Guo Q., et al. Diabetes mellitus is associated with severe infection and mortality in patients with COVID-19: a systematic review and meta-analysis. Arch Med Res. 2020;51:700&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7413048</ArticleId><ArticleId IdType="pubmed">32811670</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T., Kapoor N., Cao Y., Tapp R.J., Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab. 2021;23:870&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753574</ArticleId><ArticleId IdType="pubmed">33245182</ArticleId></ArticleIdList></Reference><Reference><Citation>Bain S.C., Czernichow S., B&#xf8;gelund M., et al. Costs of COVID-19 pandemic associated with diabetes in Europe: a health care cost model. Curr Med Res Opin. 2021;37:27&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">33306421</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. Erratum in: Nat Med. 2021;27(6):1116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>